We are live on
!
Find out more
TSW
Thompson Siegel & Walmsley Portfolio holdings
AUM
$5.7B
1-Year Est. Return
6.69%
This Fund
S&P 500
This Quarter
Est. Return
+3.4%
1 Year Est. Return
+6.69%
3 Year Est. Return
+28.78%
5 Year Est. Return
+35.85%
10 Year Est. Return
+92.81%
AUM
$5.79B
AUM Growth
+$533M
(+10%)
Cap. Flow
+$390M
Cap. Flow
% of AUM
6.74%
Top 10 Holdings %
Top 10 Hldgs %
11.72%
Holding
754
New
50
Increased
170
Reduced
211
Closed
53
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Teva Pharmaceuticals
TEVA
|
+$63.2M |
| 2 |
Portland General Electric
POR
|
+$46.9M |
| 3 |
Green Dot
GDOT
|
+$32.9M |
| 4 |
NSM
Nationstar Mortgage Holdings
NSM
|
+$27M |
| 5 |
Synopsys
SNPS
|
+$25.7M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
XLS
EXELIS INC COM STK
XLS
|
+$72.3M |
| 2 |
SIMG
SILICON IMAGE INC
SIMG
|
+$23.9M |
| 3 |
DST
DST Systems Inc.
DST
|
+$22.8M |
| 4 |
Cigna
CI
|
+$22.7M |
| 5 |
SS&C Technologies
SSNC
|
+$17M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Financials | 19.22% |
| 2 | Technology | 11.84% |
| 3 | Industrials | 10.78% |
| 4 | Utilities | 9.93% |
| 5 | Communication Services | 8.51% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
376
iShares Russell Mid-Cap Value ETF
IWS
$15.6B
| $241K | ﹤0.01% |
3,200
-52,036
| -94% | -$3.88M |
|
377
iShares S&P GSCI Commodity-Indexed Trust
GSG
$998M
| $239K | ﹤0.01% |
12,250
-10,200
| -45% | -$205K |
|
378
McDonald's
MCD
$192B
| $238K | ﹤0.01% |
2,443
+64
| +3% | +$6.07K |
|
379
W.R. Berkley
WRB
$26.9B
| $234K | ﹤0.01% |
15,660
| – | – |
|
380
Abbott
ABT
$183B
| $226K | ﹤0.01% |
4,886
-1,670
| -25% | -$76.7K |
|
381
El Pollo Loco
LOCO
$501M
| $225K | ﹤0.01% |
+8,800
| New | +$219K |
|
382
Honeywell
HON
$77B
| $219K | ﹤0.01% |
2,337
| – | – |
|
383
Vanguard FTSE Developed Markets ETF
VEA
$229B
| $215K | ﹤0.01% |
5,405
| – | – |
|
|
AET
384
DELISTED
Aetna Inc
AET
| $214K | ﹤0.01% |
2,007
-851
| -30% | -$83.4K |
|
|
HOLX
385
DELISTED
Hologic
HOLX
| $205K | ﹤0.01% |
6,221
-298,111
| -98% | -$9.15M |
|
386
Phillips 66
PSX
$84.9B
| $205K | ﹤0.01% |
2,612
| – | – |
|
387
International Paper
IP
$21.6B
| $204K | ﹤0.01% |
3,891
| – | – |
|
388
Sanofi
SNY
$103B
| $201K | ﹤0.01% |
+4,064
| New | +$194K |
|
389
McKesson
MCK
$100B
| $189K | ﹤0.01% |
834
| – | – |
|
390
Newmont
NEM
$98.7B
| $187K | ﹤0.01% |
8,600
+600
| +8% | +$14K |
|
|
PCL
391
DELISTED
PLUM CREEK TIMBER CO (REIT)
PCL
| $185K | ﹤0.01% |
4,250
| – | – |
|
|
RDS.A
392
DELISTED
Royal Dutch Shell PLC ADS Class A
RDS.A
| $184K | ﹤0.01% |
3,082
-50
| -2% | -$3.17K |
|
|
EXXI
393
DELISTED
ENERGY XXI LTD COM SHS
EXXI
| $179K | ﹤0.01% |
49,200
-3,331,925
| -99% | -$11.6M |
|
394
Boston Scientific
BSX
$69.5B
| $178K | ﹤0.01% |
10,000
| – | – |
|
395
General Dynamics
GD
$104B
| $174K | ﹤0.01% |
1,283
| – | – |
|
396
Mondelez International
MDLZ
$79.5B
| $174K | ﹤0.01% |
4,808
-39
| -0.8% | -$1.41K |
|
397
Rogers Communications
RCI
$18.3B
| $173K | ﹤0.01% |
5,177
+127
| +3% | +$4.58K |
|
|
CMA
398
DELISTED
Comerica
CMA
| $169K | ﹤0.01% |
3,755
-425
| -10% | -$19K |
|
399
Biogen
BIIB
$30B
| $167K | ﹤0.01% |
396
| – | – |
|
400
Kinder Morgan
KMI
$71.7B
| $160K | ﹤0.01% |
3,800
-113
| -3% | -$4.68K |
|
Similar funds
PI
ACM
VH
O
XT
DCP
HW
AAM
Thompson Siegel & Walmsley's Q1 2015 Portfolio in Review
As of Q1 2015, Thompson Siegel & Walmsley held 754 positions worth $5.79B, up 10% from $5.26B the previous quarter. Its ten largest holdings account for 12% of the portfolio.
Thompson Siegel & Walmsley deployed $390M of net new capital in Q1 2015, opening 50 new positions and adding to 170 existing holdings. Its largest new stake was Portland General Electric: 1,242,676 shares worth $46.1M.
By sector, the portfolio is most concentrated in Financials at 19% of assets, down from 19% a quarter earlier, followed by Technology and Industrials.
On the sell side, the largest reduction was EXELIS INC COM STK, an estimated $72.3M trimmed.
- Thompson Siegel & Walmsley's largest Q1 2015 buy was Portland General Electric: 1,242,676 shares worth $46.1M.
- Thompson Siegel & Walmsley added most to Teva Pharmaceuticals in Q1 2015, an estimated $63.2M increase.
- Thompson Siegel & Walmsley's biggest Q1 2015 reduction was EXELIS INC COM STK, cutting an estimated $72.3M.
- Thompson Siegel & Walmsley fully exited SILICON IMAGE INC in Q1 2015, selling an estimated $23.9M.
- Thompson Siegel & Walmsley's ten largest holdings make up 12% of its $5.79B portfolio in Q1 2015.
- Thompson Siegel & Walmsley opened 50 new positions and closed 53 in Q1 2015.
- Thompson Siegel & Walmsley's portfolio value rose 10% quarter-over-quarter to $5.79B.
Based on Thompson Siegel & Walmsley's 13F filing for Q1 2015, filed 13 May 2015.